Form 4: Pfizer Director Acquires Phantom Stock Units

Pfizer Inc. director James Quincey acquired 1,595.307 phantom stock units, representing deferred compensation.

Summary

• James Quincey, a Director at Pfizer Inc., acquired 1,595.307 phantom stock units on June 26, 2026.
• These units are part of deferred director's compensation and include dividend equivalents.
• The units will be settled in cash or common stock upon Quincey's retirement from the Board of Directors.
• The acquisition price for these units was $24.29 per unit, totaling $38,679.957.
• Following this transaction, Quincey beneficially owns 87,993.957 phantom stock units directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine part of executive compensation and does not indicate a significant change in the company's financial performance or strategic direction.

Positives

• Director James Quincey's acquisition of phantom stock units indicates continued commitment and investment in the company.
• The acquisition is part of a deferred compensation plan, suggesting a structured approach to executive compensation and retention.

Future Outlook

The phantom stock units are settled in cash or common stock at the director's election following retirement from the Board of Directors, indicating a future payout event.

Industry Context

StockSavvy.ai notes that Form 4 filings, like this one from Pfizer Inc., are standard disclosures for insider transactions. Such filings are crucial for investors to monitor insider activity, which can sometimes signal confidence or concerns about a company's prospects within the pharmaceutical industry.

Stakeholder Impact

• Shareholders: The transaction is a standard compensation event and is unlikely to have a direct, immediate impact on share price. However, it reflects ongoing executive compensation practices.
• Employees: The deferred compensation structure for directors can be seen as a model for long-term incentive plans, potentially influencing employee compensation strategies.
• Management: Reinforces the alignment of director interests with long-term company performance through equity-based compensation.

Next Steps

• Settlement of phantom stock units in cash or common stock upon Director James Quincey's retirement from the Board of Directors.

Key Dates

Keywords

Pfizer Inc., PFE, Form 4, Insider Trading, Stock Options, Deferred Compensation, Director Compensation, Phantom Stock Units, Beneficial Ownership